Recent Company News

• 11:11 PM ET Jul 02, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (64 total)

• 10:51 PM ET Jun 28, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (58 total)

• 01:02 PM ET Jun 26, 2026
  

  Santen Pharmaceutical releases CGR report (¥2128.5000, 0)

• 10:39 PM ET Jun 25, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (67 total)

• 10:43 PM ET Jun 24, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (50 total)

• 04:15 AM ET Jun 19, 2026
  

  Santen Pharmaceutical obtains Japan production and marketing approval for Rhopressa Ophthalmic Solution 0.02% (¥1874.0000, 0)

• 06:53 AM ET Jun 04, 2026
  

  Cloudbreak Pharma completes 12-month final patient visit for phase III clinical trial of CBT-001; to deliver top-line data in Q3 (HK$1.18, 0.00)

• 11:14 PM ET May 24, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (176 total)

• 10:43 PM ET May 20, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (85 total)

• 11:13 PM ET May 19, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (95 total)